Food Science of Animal Resources (Food Sci. Anim. Resour.) is an international, peer-reviewed bimonthly journal publishing original research and reviews on basic and applied aspects of the use of animal resources including the meat, egg, dairy, and edible insect/worm products. Food Sci. Anim. Resour. is published and distributed by the Korean Society for Food Science of Animal Resources.
17 July 2025 in Journal of Agriculture and Food Research
Chili anthracnose, caused by Colletotrichum truncatum, causes significant yield loss in chili production. In this study, we investigated the elicitor properties of a rhamnolipid (RL)-enriched PA3 fraction derived from Pseudomonas aeruginosa SWUC02 in inducing systemic resistance in yellow chili seedlings and antifungal activity against C. truncatum CFPL01 (Col). Fractionation of the ethyl acetate extract yielded 12 fractions, with PA3 demonstrating the most effective disease suppression, reducing the disease severity index to 4 ± 7.35% at 7 days post-inoculation compared with Col inoculation alone (83 ± 23.57%). PA3 also exhibited direct antifungal activity, inhibiting Col mycelial growth by 41 ± 0.96% at 200 µg/mL. Subfractionation revealed PA3 as a mixture of mono- and di-RLs, confirmed by 1H nuclear magnetic resonance and electrospray ionization mass spectrometry data. Additionally, PA3 enhanced seed germination and promoted plant growth without causing phytotoxicity. Transcriptomics revealed that PA3 pre-treatment prior to Col infection primed the defense response, upregulating defense-related genes involved in the phenylpropanoid, flavonoid, and jasmonic acid biosynthesis pathways, as well as those associated with cell wall reinforcement. Our findings highlight the potential of RL-enriched PA3 as both an antifungal agent and a plant defense elicitor, with transcriptome data providing new insights into defense priming and resistance pathways in chili, offering an eco-friendly solution for sustainable anthracnose management.
Pseudomonas aeruginosa is an abundant bacterium in nature. Several P. aeruginosa strains are capable of producing a wide range of secondary metabolites with broad-spectrum high antimicrobial activity. This study aims to identify antimicrobial activity genes of P. aeruginosa SWUC02 by whole-genome sequencing analysis. Whole genome sequencing of P. aeruginosa SWUC02 was proceeded with the BGISEQ-500 sequencing system. The genome of P. aeruginosa SWUC02 is a single circular chromosome with 6,404,055 bp. 6,214 coding sequences were identified by RAST. We compared P. aeruginosa SWUC02 against two reference strains: P. aeruginosa LV and P. aeruginosa PAO1, according to their antimicrobial activity. Our result shows that several antimicrobial gene clusters including bacteriocins, secondary metabolites, and siderophores are shared among P. aeruginosa SWUC02 and the two reference strains. The notable difference arises in secondary metabolite gene clusters where we identified pyocyanine and thanamycin in P. aeruginosa SWUC02 genome, which are absent from the reference strains. P. aeruginosa SWUC02 shows the potential for being a prospective antagonist and warrants a follow up study for antimicrobial compound production.
Endocan, a component of endothelial glycocalyx, is a recognized biomarker of endothelial dysfunction in various inflammatory and infectious diseases. Malaria, characterized by marked endothelial activation and microvascular pathology, may involve endocan, but its role remains unclear. This study aimed to assess serum endocan levels in various clinical presentations of malaria and evaluate its correlation with laboratory parameters of disease severity. Leftover serum samples from 99 participants were categorized into four groups: healthy controls (n = 20), Plasmodium vivax malaria (n = 36), uncomplicated Plasmodium falciparum malaria (n = 30), and severe P. falciparum malaria (n = 13). Serum endocan concentrations were measured via enzyme-linked immunosorbent assay on day 0 (pre-treatment) and day 7 (post-treatment). Correlation analyses examined associations between endocan levels and laboratory parameters, including parasite density, white blood cell count, haemoglobin, and platelet count. All malaria groups showed significantly higher serum endocan levels compared to healthy controls (p < 0.0001). Levels were highest in severe P. falciparum (median 4.67 [IQR 2.85-7.93] ng/ml), followed by uncomplicated P. falciparum (median 3.27 [IQR 2.24-4.33] ng/ml), and P. vivax malaria (median 1.85 [IQR 1.44-3.23] ng/ml). Endocan correlated positively with parasite density in P. vivax (rs = 0.4632, p = 0.0066) and severe P. falciparum malaria (rs = 0.6264, p = 0.0251) and negatively with platelet count in P. vivax infections (rs = - 0.5523, p = 0.001). Serum endocan is elevated in malaria in a severity-dependent manner-highest in severe P. falciparum malaria-and correlates with circulating parasite density and thrombocytopenia, highlighting its potential as a biomarker of endothelial injury in malaria.